Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Essen Biotech
Iambic Therapeutics, Inc
Amgen
Var2 Pharmaceuticals
Mayo Clinic
National Institutes of Health Clinical Center (CC)
LigaChem Biosciences, Inc.
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Telix Pharmaceuticals (Innovations) Pty Limited
PharmaMar
Apollomics Inc.
Columbia University
Stanford University
Universidade Federal de Pernambuco
Aminex Therapeutics, Inc.
Washington University School of Medicine
NGM Biopharmaceuticals, Inc
University of Florida
Quadriga Biosciences, Inc.
Hospices Civils de Lyon
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Shenzhen BinDeBio Ltd.
Southwest Hospital, China
Shenzhen BinDeBio Ltd.
Icahn School of Medicine at Mount Sinai
Stanford University
M.D. Anderson Cancer Center
University of Arizona
National Cancer Institute (NCI)
SWOG Cancer Research Network
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
NYU Langone Health
Case Comprehensive Cancer Center
Pharmacyclics LLC.